Reading OSCR? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track OSCR free→Reading OSCR? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track OSCR free→QuarterlyIQ Insights · OSCR
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Regulation FD Disclosure. Oscar Health, Inc. (the “Company”) will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference (the “Conference”) on June 8, 2026 at approximately 11:20 AM ET. At the Conference, the Company plans to provide a business update and reaffirm its full year 2026 guidance, as previously provided in its financial results press release dated February 10, 2026. A live audio webcast will be available via the Investor Relations page of the…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On May 29, 2026, Oscar Health, Inc. and Oscar Management Corporation (together, the “Company”) and Mario Schlosser entered into an amended and restated employment agreement (the “A&R Employment Agreement”), effective as of June 1, 2026 (the “Effective Date”), in connection with Mr. Schlosser’s transition from President of Technology and Chief Techn…
and Exhibit 99.1 of this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information and exhibits be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Regulation FD Disclosure. Guidance Reaffirmation Oscar Health, Inc. (the “Company”), in advance of its upcoming participation in the Medicarians 2026 conference on April 21, 2026, is reaffirming the full year 2026 guidance that it provided in its financial results press release for the fourth quarter and full year 2025 dated February 10, 2026. As previously announced, the Company expects to release first quarter 2026 financial results before the market opens on Wednesday, May 6, 2026, and hos…
Regulation FD Disclosure. Oscar Health, Inc. (the “Company”) will participate in the 2026 Raymond James Institutional Investors Conference (the “Conference”) on March 2, 2026. At the Conference, the Company will reaffirm the full year 2026 guidance that it provided in its financial results press release for the fourth quarter and full-year 2025, dated February 10, 2026. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (…
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant . The information set forth above under
and Exhibit 99.1 of this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information and exhibits be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Entry into a Material Definitive Agreement. On February 6, 2026, Oscar Health, Inc. (the “Company”), entered into a $475.0 million secured three-year revolving credit facility (the “Revolving Credit Facility”), pursuant to a Credit Agreement (the “Credit Agreement”), by and among the Company, certain subsidiaries of the Company, as subsidiary guarantors, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto. Capitalized terms used but not defined herein have the me…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On December 22, 2025 (the “Effective Date”), Oscar Health, Inc. and Oscar Management Corporation (together, the “Company”) entered into an amended and restated employment agreement (the “A&R Employment Agreement”) with Mark T. Bertolini in connection with the forthcoming expiration of the initial employment term under the employment agreement that…
and Exhibit 99.1 of this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information and exhibits be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Other Events. On November 3, 2025, the Company and Oasis FD Holdings, LP (“Dragoneer”) entered into an Exchange Agreement (the “Agreement”) pursuant to which, until December 14, 2025, Dragoneer may elect to exchange up to $250,000,000 aggregate principal amount of the Company’s 7.25% convertible senior notes due 2031 (the “2031 Notes”), representing the balance of its 2031 Notes, for aggregate consideration consisting of (A) a number of shares of the Company’s Class A common stock (“Shares”)…
Entry Into a Material Definitive Agreement. Indenture and Notes On September 18, 2025, Oscar Health, Inc. (the “ Company ”) issued $410,000,000 aggregate principal amount of its 2.25% Convertible Senior Subordinated Notes due 2030 (the “ Notes ”). The Notes were issued pursuant to, and are governed by, an indenture (the “ Indenture ”), dated as of September 18, 2025, between the Company and U.S. Bank Trust Company, National Association, as trustee (the “ Trustee ”). Pursuant to the purchase a…
Creation of a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant. The disclosure set forth in
The Notes were issued to the initial purchasers in reliance upon Section 4(a)(2) of the Securities Act of 1933, as amended (the “ Securities Act ”), in transactions not involving any public offering. The Notes were resold by the initial purchasers to persons whom the initial purchasers reasonably believe are “qualified institutional buyers,” as defined in, and in accordance with, Rule 144A under the Securities Act. Any shares of the Company’s class A common stock that may be issued upon conve…
Termination of a Material Definitive Agreement. In connection with the offering described below, Oscar Health, Inc. (the “ Company ”) gave notice of its intent to terminate the revolving credit facility that forms part of its senior secured credit agreement, by and among the Company, Wells Fargo Bank, National Association, as lender and administrative agent, and certain other lenders party thereto from time to time, and Oscar Management Corporation, as a subsidiary guarantor, dated as of Febr…
Regulation FD Disclosure. In connection with the Offering, and as a result of the proceeds expected to be raised, the Company expects to give notice of its intent to terminate the revolving credit facility that forms part of its senior secured credit agreement, by and among the Company, Wells Fargo Bank, National Association, as lender and administrative agent, and certain other lenders party thereto from time to time, and Oscar Management Corporation, as a subsidiary guarantor, dated as of F…
Entry into a Material Definitive Agreement. On September 11, 2025, Oscar Health, Inc. (the “ Company ”) entered into an amendment (“ Amendment ”) to the Investment Agreement (the “ Investment Agreement ”) dated January 27, 2022, by and among the Company, funds affiliated with or advised by Dragoneer Investment Group, LLC (“ Dragoneer ”) and certain other purchasers identified therein. The purpose of the Amendment was to permit the Offering (as defined below) under the Investment Agreement.
Regulation FD Disclosure. Oscar Health, Inc. (the “Company”) will participate in the 2025 Wells Fargo Healthcare Conference (the “Conference”) on September 3, 2025. At the Conference, the Company will reaffirm the updated full year 2025 guidance that it provided in its preliminary financial results press release for the second quarter of 2025, dated July 22, 2025. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “E…
and Exhibit 99.1 of this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information and exhibits be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Results of Operations and Financial Condition. On July 22, 2025, Oscar Health, Inc. (the “Company”) issued a press release announcing certain preliminary financial results for the second quarter of 2025 and revising its full year 2025 outlook. A copy of the press release issued in connection with the announcement is attached and furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference. The information in
and Exhibit 99.1 of this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information and exhibits be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Regulation FD Disclosure. Oscar Health, Inc. (the “Company”) will participate in the 2025 Raymond James Institutional Investors Conference (the “Conference”) on March 3, 2025. At the Conference, the Company will reaffirm the full year 2025 guidance that it provided in its financial results press release for the fourth quarter of 2024, dated February 4, 2025. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchang…
and Exhibit 99.1 of this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information and exhibits be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of President of Oscar Insurance On January 30, 2025, the Board of Directors (the “Board”) of the Company appointed Janet Liang as EVP and President of Oscar Insurance, effective February 24, 2025. Ms. Liang will be responsible for overseeing the Company’s insurance and operations functions. This newly created role will centralize leader…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.